AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34231653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RT groups (gym and freew)
Number of subjects: 74
Study 32744134 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal elicitation tool (demographics questionnaire and goal elicitation worksheet)
Number of subjects: 96
Study 32744134 — intervention group
Group type: COMPARATOR
Intervention: Control group (demographics questionnaire only)
Number of subjects: 96
Study 35264227 — intervention group
Group type: EXPERIMENTAL
Intervention: Change of gloves and sterile instruments before closing the abdominal wall
Number of subjects: 12800
Study 35264227 — intervention group
Group type: COMPARATOR
Intervention: No changing gloves or using separate, sterile instruments (standard practice)
Number of subjects: 12800
Study 34860737 — intervention group
Group type: EXPERIMENTAL
Intervention: integrated video‐based instruction
Number of subjects: 66
Study 34860737 — intervention group
Group type: EXPERIMENTAL
Intervention: integrated simulator‐based instruction
Number of subjects: 66
Study 34860737 — intervention group
Group type: COMPARATOR
Intervention: video‐based procedural‐only instruction
Number of subjects: 66
Study 34020105 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention group
Number of subjects: 279
Study 34020105 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 279
Study 34020105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of boys
Number of subjects: 279
Study 32615321 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-C levels
Number of subjects: 80
Study 32615321 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-C levels in females
Number of subjects: 80
Study 32615321 — intervention group
Group type: COMPARATOR
Intervention: HDL-C levels in males
Number of subjects: 80
Study 35312171 — intervention group
Group type: EXPERIMENTAL
Intervention: NUTRIOSE® (RD)
Number of subjects: 50
Study 35312171 — intervention group
Group type: COMPARATOR
Intervention: Control product
Number of subjects: 50
Study 33334129 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 33334129 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 32264800 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 2058
Study 36475905 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (3 doses of 2.7 × 10^6 PfSPZ)
Number of subjects: 80
Study 36475905 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study 34027920 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) with Beta-Alanine (BA) supplementation
Number of subjects: 44
Study 34027920 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) with Placebo (PL)
Number of subjects: 44
Study 34027920 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 44
Study 32141817 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg cholecalciferol
Number of subjects: 90
Study 32141817 — intervention group
Group type: COMPARATOR
Intervention: 1 mL normal saline (placebo)
Number of subjects: 90
Study 36138260 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 0
Study 36138260 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 0
Study 36138260 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 0
Study 36138260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33245956 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning laser Doppler flowmetry (SLDF)
Number of subjects: 398
Study 33245956 — intervention group
Group type: EXPERIMENTAL
Intervention: Unattended automated office systolic BP
Number of subjects: 398
Study 33245956 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid femoral pulse wave velocity
Number of subjects: 398
Study 32182747 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA + EPA supplementation (2.1 g/day of DHA + 240 mg/day of EPA)
Number of subjects: 15
Study 32182747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 34982095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 32301973 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous ADASC implantation (G-1)
Number of subjects: 14
Study 32301973 — intervention group
Group type: EXPERIMENTAL
Intervention: Decellularized human corneal stroma (G-2)
Number of subjects: 14
Study 32301973 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous ADASCs + decellularized human corneal stroma (G-3)
Number of subjects: 14
Study 36121656 — intervention group
Group type: EXPERIMENTAL
Intervention: aBWL
Number of subjects: 382
Study 36121656 — intervention group
Group type: EXPERIMENTAL
Intervention: aBWL + BE
Number of subjects: 382
Study 36121656 — intervention group
Group type: EXPERIMENTAL
Intervention: aBWL + SDT
Number of subjects: 382
Study 33007492 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh Frozen Bone (FFB)
Number of subjects: 15
Study 33007492 — intervention group
Group type: COMPARATOR
Intervention: Autogenous Bone (AB)
Number of subjects: 15
Study 32655006 — intervention group
Group type: COMPARATOR
Intervention: Hyperinsulinemic diets (EDIH quintile 5)
Number of subjects: 49317
Study 32655006 — intervention group
Group type: COMPARATOR
Intervention: Proinflammatory diets (EDIP quintile 5)
Number of subjects: 49317
Study 32655006 — intervention group
Group type: COMPARATOR
Intervention: EDIP
Number of subjects: 49317
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP4 inhibition (sitagliptin) during ramipril treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (NK1 receptor blocker) during ramipril or valsartan treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: COMPARATOR
Intervention: Placebo during ramipril treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: COMPARATOR
Intervention: Placebo during valsartan treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: COMPARATOR
Intervention: Placebo during amlodipine treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + placebo during ramipril treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + placebo during valsartan treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + placebo during amlodipine treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + aprepitant during ramipril treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + aprepitant during valsartan treatment
Number of subjects: 106
Study 35045722 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + aprepitant during amlodipine treatment
Number of subjects: 106
Study 32588274 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based intervention including action planning, coping planning, and self-monitoring.
Number of subjects: 200
Study 32588274 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (standard care).
Number of subjects: 200
Study 35292982 — intervention group
Group type: EXPERIMENTAL
Intervention: Piano training
Number of subjects: 134
Study 35292982 — intervention group
Group type: COMPARATOR
Intervention: Musical culture/music listening group
Number of subjects: 134
Study 32496104 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual eye movement desensitization and reprocessing (EMDR)
Number of subjects: 105
Study 32496104 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-administered stress management with a trauma focus (SMT)
Number of subjects: 105
Study 32496104 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-administered psychological first aid (PFA)
Number of subjects: 105
Study 32427114 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Coaching Chatbot intervention (12 weeks) with cues and intrinsic/extrinsic rewards
Number of subjects: 106
Study 32427114 — intervention group
Group type: COMPARATOR
Intervention: Control group (first 4 weeks without intrinsic rewards, then same rewards as intervention from week 5 to 12)
Number of subjects: 106
Study 32427114 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (after 12 weeks of intervention)
Number of subjects: 106
Study 36103557 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm delivery group (n = 48)
Number of subjects: 144
Study 36103557 — intervention group
Group type: COMPARATOR
Intervention: Term delivery group (n = 96)
Number of subjects: 144
Study 33874661 — intervention group
Group type: EXPERIMENTAL
Intervention: parodontax Comprehensive Protection toothpaste
Number of subjects: 119
Study 33874661 — intervention group
Group type: COMPARATOR
Intervention: toothpaste without sodium bicarbonate (control)
Number of subjects: 119
Study 32511114 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led advanced cardiac life support
Number of subjects: 0
Study 32511114 — intervention group
Group type: COMPARATOR
Intervention: Online advanced cardiac life support
Number of subjects: 0
Study 35143552 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised Physiotherapy
Number of subjects: 300
Study 35143552 — intervention group
Group type: COMPARATOR
Intervention: Advice
Number of subjects: 300
Study 35958354 — intervention group
Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 773
Study 35958354 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 773
Study 35958354 — intervention group
Group type: COMPARATOR
Intervention: NTD registry
Number of subjects: 773
Study 32307650 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG) - intrabronchially inoculated with M. haemolytica (6.5×10^6 CFU/mL)
Number of subjects: 14
Study 32307650 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 14
Study 32307650 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG)
Number of subjects: 14
Study 33929627 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 20
Study 33929627 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched education control
Number of subjects: 20
Study 32808179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 ppm F toothpaste
Number of subjects: 60
Study 32808179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 TMPnano toothpaste
Number of subjects: 60
Study 32808179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 TMPmicro toothpaste
Number of subjects: 60
Study 32808179 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 60
Study 35522618 — intervention group
Group type: EXPERIMENTAL
Intervention: Leap motion control and conventional therapy
Number of subjects: 40
Study 35522618 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 40
Study 33829236 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 1809
Study 33829236 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital food
Number of subjects: 1809
Study 33829236 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip strength (HGS) measurement
Number of subjects: 1809
Study 34210409 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus Aspirin 100 mg once daily
Number of subjects: 27195
Study 34210409 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 27195
Study 34210409 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban plus Aspirin
Number of subjects: 27195
Study 34210409 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 27195
Study 33095139 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg ianalumab
Number of subjects: 27
Study 33095139 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg ianalumab
Number of subjects: 27
Study 33095139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 36342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Olpasiran 10 mg every 12 weeks
Number of subjects: 281
Study 36342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Olpasiran 75 mg every 12 weeks
Number of subjects: 281
Study 36342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Olpasiran 225 mg every 12 weeks
Number of subjects: 281
Study 36342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Olpasiran 225 mg every 24 weeks
Number of subjects: 281
Study 36342163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 33529342 — intervention group
Group type: EXPERIMENTAL
Intervention: AA+ (functional amino acids: Thr, Met, Trp at 120% of requirements)
Number of subjects: 64
Study 33529342 — intervention group
Group type: EXPERIMENTAL
Intervention: AA+
Number of subjects: 64
Study 33529342 — intervention group
Group type: EXPERIMENTAL
Intervention: HP (high protein)
Number of subjects: 64
Study 33529342 — intervention group
Group type: EXPERIMENTAL
Intervention: HP
Number of subjects: 64
Study 33529342 — intervention group
Group type: COMPARATOR
Intervention: CT (control group with sterile saline solution)
Number of subjects: 64
Study 33529342 — intervention group
Group type: EXPERIMENTAL
Intervention: ST (saline solution containing Salmonella Typhimurium)
Number of subjects: 64
Study 32298704 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 22
Study 32298704 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 22
Study 35017007 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Radiation Therapy (cRT)
Number of subjects: 110
Study 35017007 — intervention group
Group type: COMPARATOR
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 110
Study 34273551 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Training (PST) / Descubriendo Soluciones Juntos (DSJ) sessions, three vs. six sessions with and without booster sessions
Number of subjects: 0
Study 34273551 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35680195 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolute Onyx polymer‐based zotarolimus‐eluting stents (ZES)
Number of subjects: 1996
Study 35680195 — intervention group
Group type: COMPARATOR
Intervention: BioFreedom polymer‐free biolimus A9‐coated stents (DCS)
Number of subjects: 1996
Study 34518033 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with choline fenofibrate and statin
Number of subjects: 127
Study 34518033 — intervention group
Group type: COMPARATOR
Intervention: Statin monotherapy
Number of subjects: 127
Study 35985854 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown fabricated from confocal microscopy-based IOS (Group T)
Number of subjects: 35
Study 35985854 — intervention group
Group type: COMPARATOR
Intervention: Crown fabricated from dual camera triangulation-based IOS (Group I)
Number of subjects: 35
Study 33038051 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training
Number of subjects: 16
Study 33038051 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 33125266 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating biomarkers
Number of subjects: 451933
Study 33125266 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-1 (insulin-like growth factor 1)
Number of subjects: 451933
Study 33125266 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein(a)
Number of subjects: 451933
Study 33125266 — intervention group
Group type: EXPERIMENTAL
Intervention: ALT (alanine aminotransferase)
Number of subjects: 451933
Study 35902898 — intervention group
Group type: EXPERIMENTAL
Intervention: TA4415V
Number of subjects: 92
Study 35902898 — intervention group
Group type: COMPARATOR
Intervention: Reference trastuzumab
Number of subjects: 92
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking started 15 min after the meal
Number of subjects: 6
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: Different exercise types (aerobic vs. resistance vs. combined)
Number of subjects: 6
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: Different aerobic exercise types (walking vs. cycling vs. elliptical)
Number of subjects: 6
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking
Number of subjects: 6
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 min of brisk walking
Number of subjects: 6
Study 33481486 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 and 20 min of cumulative exercise
Number of subjects: 6
Study 32682938 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg triamcinolone acetonide + 2% lidocaine hydrochloride
Number of subjects: 56
Study 32682938 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone acetonide + 2% lidocaine hydrochloride
Number of subjects: 56
Study 32682938 — intervention group
Group type: COMPARATOR
Intervention: Both groups (40 mg and 10 mg)
Number of subjects: 56
Study 35894410 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate solution (100 ml)
Number of subjects: 60
Study 35894410 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate popsicle (100 ml)
Number of subjects: 60
Study 35894410 — intervention group
Group type: COMPARATOR
Intervention: Control (fasting)
Number of subjects: 60
Study 33247691 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation of 6,000 IU (1.8 mg RAEs) per day
Number of subjects: 32
Study 33247691 — intervention group
Group type: COMPARATOR
Intervention: No vitamin A supplementation (Control)
Number of subjects: 32
Study 34773130 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 562
Study 34773130 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 562
Study 33535899 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) therapy, Compex-Winplate™, 3 sessions of 15 minutes per week for 8 weeks
Number of subjects: 26
Study 33535899 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 26
Study 32660432 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling arm (n = 17,997)
Number of subjects: 36390
Study 32660432 — intervention group
Group type: COMPARATOR
Intervention: Pap smear arm (n = 18,393)
Number of subjects: 36390
Study 35033049 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (brisk walking 30min/day, 4‐5days/week for 6 months)
Number of subjects: 225
Study 35033049 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 225
Study 34124967 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training group (two training sessions of 1.5-2.5 hours each)
Number of subjects: 27
Study 34124967 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive training group (two video-watching sessions)
Number of subjects: 27
Study 34124967 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 27
Study 33077241 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Very-Low-Energy Diet (VLED)
Number of subjects: 164
Study 33077241 — intervention group
Group type: COMPARATOR
Intervention: Standard Dietary Intervention (SDI)
Number of subjects: 164
Study 36433713 — intervention group
Group type: EXPERIMENTAL
Intervention: danuglipron 40-120 mg BID
Number of subjects: 37
Study 36433713 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 37
Study 34863444 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 60
Study 34863444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32223482 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic fluid (5% dextrose in 0.45% NaCl)
Number of subjects: 108
Study 32223482 — intervention group
Group type: COMPARATOR
Intervention: Isotonic fluid (5% dextrose in 0.9% NaCl)
Number of subjects: 108
Study 32029134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 5806
Study 32029134 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 5806
Study 35230245 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive suggestions group
Number of subjects: 133
Study 35230245 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 133
Study 32073511 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF+ status
Number of subjects: 93
Study 32073511 — intervention group
Group type: EXPERIMENTAL
Intervention: WNT pathway mutations
Number of subjects: 93
Study 32073511 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF pathway mutations
Number of subjects: 93
Study 35392958 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrapping fundus of the excluded part of the stomach
Number of subjects: 100
Study 35392958 — intervention group
Group type: COMPARATOR
Intervention: Nonwrapping fundus of the excluded part of the stomach
Number of subjects: 100
Study 33741815 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb therapies after stroke
Number of subjects: 0
Study 33741815 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomised approach for ARAT analysis
Number of subjects: 0
Study 33741815 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical techniques for ARAT analysis
Number of subjects: 0
Study 32554999 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip Resurfacing (HR)
Number of subjects: 203
Study 32554999 — intervention group
Group type: COMPARATOR
Intervention: 28-mm metal-on-metal Total Hip Replacement (THA)
Number of subjects: 203
Study 35398192 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted social skills training (ScouT)
Number of subjects: 100
Study 35398192 — intervention group
Group type: COMPARATOR
Intervention: Supportive resource activation treatment (STARK)
Number of subjects: 100
Study 34010238 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal HPV self-sampling
Number of subjects: 14765
Study 34010238 — intervention group
Group type: COMPARATOR
Intervention: Cervical sampling by midwives
Number of subjects: 14765